Optimal Teneceplase Dosing for Elders Identified, BMI Associated With Worse Cognitive Decline, Slight Improvements in Migraine Preventive Use

Press/Media

Period	5 Feb 2022

Media coverage

Title	Optimal Teneceplase Dosing for Elders Identified, BMI Associated With Worse Cognitive Decline, Slight Improvements in Migraine Preventive Use
Media name/outlet	Neurology Live
Country/Territory	United States
Date	5/02/22
URL	https://www.neurologylive.com/view/optimal-teneceplase-dosing-elders-identified-bmi-associated-with-worse-cognitive-decline-improvements-migraine-preventive-use
Persons	Michal Schnaider Beeri